China Everbright Bank Co Ltd (601818)
Shanghai Stock Exchange · China · prices in CNY · close of 23 Oct 2026
Key indicators
| Last close | CNY 2.990 |
|---|---|
| 52-week range | 2.870 – 3.720 |
| Return, 1 month / 3 months | −0.3% / −5.4% |
| Return, 1 year / 3 years | −15.5% / +0.0% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 16.4% |
| Worst drawdown (1 year) | -21.3% |
| Average daily value traded | 603.00M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Everbright Bank is a commercial bank based in Beijing that serves individuals, businesses and institutional clients across China. It offers deposit accounts, consumer and corporate lending, trade finance, wealth management products and payment services through its branch network. The bank also provides treasury and interbank services, and it operates as part of the China Everbright Group, a state-linked financial conglomerate with interests spanning banking, securities and insurance.
China Everbright Bank Co Ltd trades under the code 601818 on the Shanghai Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Everbright Bank Co Ltd (601818) trades on the Shanghai Stock Exchange in China. It last closed at CNY 2.990 on 23 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 119 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.5% and over the last three months it fell 5.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -5.7% | ||
| From 52-week high | -18.5% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.4% | ||
| 6-month return | -6.0% | ||
| 12-month return, skipping the last month | -15.3% | ||
| Stability (higher is calmer) | 97 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.3% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 603.00M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.5% |
|---|---|
| 1 month | −0.3% |
| 3 months | −5.4% |
| 6 months | −6.0% |
| 1 year | −15.5% |
| 3 years | +0.0% |
| 5 years | −2.3% |
Signals
| 50-day / 200-day average | 3.038 / 3.169 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.047 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Jul 2023 | CNY 0.1900 |
| 29 Jun 2022 | CNY 0.2010 |
| 21 Jul 2021 | CNY 0.2100 |
| 24 Jun 2020 | CNY 0.2140 |
| 26 Jun 2019 | CNY 0.1610 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.